RespireRx Pharmaceuticals Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
RespireRx Pharmaceuticals Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2022.
  • RespireRx Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$396K, a 16.3% increase year-over-year.
  • RespireRx Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$1.8M, a 30.6% increase year-over-year.
  • RespireRx Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$2.1M, a 33.1% increase from 2021.
  • RespireRx Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$3.14M, a 26.9% increase from 2020.
  • RespireRx Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$4.3M, a 103% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$2.1M +$1.04M +33.1% Jan 1, 2022 Dec 31, 2022 10-Q 2023-05-22
2021 -$3.14M +$1.16M +26.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
2020 -$4.3M -$2.19M -103% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-15
2019 -$2.12M +$477K +18.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-04-15
2018 -$2.59M +$1.7M +39.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-04-14
2017 -$4.29M +$4.94M +53.5% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-16
2016 -$9.23M -$3.27M -54.8% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-17
2015 -$5.96M -$3.25M -120% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
2014 -$2.71M -$1.51M -125% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-29
2013 -$1.2M +$6.37M +84.1% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-30
2012 -$7.57M -$5.32M -236% Jan 1, 2012 Dec 31, 2012 10-K 2015-01-06
2011 -$2.26M -$3.88M -238% Jan 1, 2011 Dec 31, 2011 10-K 2014-10-14
2010 $1.63M Jan 1, 2010 Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.